PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Pharmacology, College of Medicine, The University of Arizona, Tucson, Arizona 85724, United States.\', \'The Center for Innovation in Brain Sciences, The University of Arizona Health Sciences, Tucson, Arizona 85704, United States.\', \'Bright Rock Path Consulting, LLC, Tucson, Arizona 85704, United States.\', \'Department of Cellular & Molecular Medicine, College of Medicine, The University of Arizona, Tucson, Arizona 85724, United States.\', \'Cancer Biology Graduate Interdisciplinary Program, University of Arizona, Tucson, Arizona 85724, United States.\', \'Bio5 Institute, University of Arizona, Tucson, Arizona 85724, United States.\', \'Department of Immunobiology, College of Medicine, University of Arizona, Tucson, Arizona 85724, United States.\', \'Regulonix, LLC, Tucson, Arizona 85718, United States.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1021/acschemneuro.0c00619
?:hasPublicationType
?:journal
  • ACS chemical neuroscience
is ?:pmid of
?:pmid
?:pmid
  • 33787218
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.442
?:rankingScore_hIndex
  • 46
is ?:relation_isRelatedTo_publication of
?:title
  • Novel Compounds Targeting Neuropilin Receptor 1 with Potential To Interfere with SARS-CoV-2 Virus Entry.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33787218>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33787218>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all